
Arthroplasty
Effect of buprenorphine added to bupivacine for femoral nerve block in TKA
J Arthroplasty. 2015 Feb;30(2):320-4.Forty-eight patients were divided into 2 groups to compare the use of a 0.3mg dose of buprenorphine as an adjuvant in femoral nerve block to the sole use of femoral nerve block with a solution of 0.25% bupivacaine and adrenaline following total knee arthroplasty. The purpose of the study was to determine whether buprenorphine, a long-lasting opioid, would be able to improve the quality and duration of the administered femoral nerve block. A numerical rating scale (NRS) was the primary outcome of interest, and it was measured at 12, 24, 36, 48, 60, and 72 hours following the procedure. Patients who received the additional dose of buprenorphine indicated a lower level of pain at postoperative 12 hours than patients in the control group.
Unlock the full article
Get unlimited access to OrthoEvidence with a free trial
Start TrialCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or continue reading this full article
Register Now

Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.